am 251 has been researched along with Chronic Hepatitis C in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Excerpt | Relevance | Reference |
---|---|---|
"CB1R antagonist improved glucose metabolism disorders by an increase in glucose uptake and a decrease in glucose production, and inhibited HCV replication." | 1.40 | Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. ( Chen, MY; Shi, YG; Sun, LJ; Wan, L; Yu, JW; Zhang, XY, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sun, LJ | 1 |
Yu, JW | 1 |
Wan, L | 1 |
Zhang, XY | 1 |
Shi, YG | 1 |
Chen, MY | 1 |
1 other study available for am 251 and Chronic Hepatitis C
Article | Year |
---|---|
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Topics: AMP-Activated Protein Kinases; Arachidonic Acids; Cell Line; Cell Survival; Coculture Techniques; Cy | 2014 |